At present, it is still unclear whether tumor progression with abundant TAMs could be enhanced or these TAMs could be polarized to M2 phenotype mainly by CCL2 overexpression in ccRCC. The gene discussed is CCL2; the disease is nonpapillary renal cell carcinoma.